Sljedeći

Auto Play

Acute Myeloid Leukemia: Incorporating Novel Treatment Approaches into Clinical Pathways

0 Pogledi • 07/04/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

Earn CME for related activities: https://www.naccme.com/oln

This on-demand webcast examines the latest clinical and pharmacoeconomic data surrounding emerging therapies in AML, including novel chemotherapy formulations, FLT3 inhibitors, and IDH inhibitors for informed pathway placement.

© 2018 NACCME, an HMP Company

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play